- $37.67m
- -$70.63m
- 21
- 52
- 57
- 39
Annual cashflow statement for NextCure, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -33.7 | -36.6 | -69.4 | -74.7 | -62.7 |
| Depreciation | |||||
| Non-Cash Items | 1.89 | 7.91 | 10.3 | 9.95 | 8.76 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6.46 | -19.7 | -2.36 | 6.77 | -2.7 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -35.6 | -45 | -57.3 | -53.9 | -53 |
| Capital Expenditures | -3.37 | -7.13 | -2.36 | -2.12 | -0.82 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -301 | 50.7 | 39 | 70.1 | 40.1 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -304 | 43.5 | 36.6 | 68 | 39.3 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 243 | -1.42 | -3.27 | 0.2 | 0.154 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -96.5 | -2.85 | -23.9 | 14.3 | -13.5 |